Schedule 13G ownership disclosure
CANCER GENETICS INC.
Security class unavailable · CUSIP: 13739U104
Event date: 2016-05-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 756,500
- Percent of class
- 4.6900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000153
- Form type
- SC 13G
- Filer
- Vyant Bio, Inc.
- CIK
- CIK 1349929
- Filed
- May 24, 2016
- Reporting period
- May 20, 2016
- Description
- Schedule 13G beneficial ownership